Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News


May 7, 2013
Contained manufacturing ops underway  Read More »

May 7, 2013
Wierman to lead oncology efforts  Read More »

May 7, 2013
Revenues up 11% in the quarter  Read More »

May 6, 2013
Will develop test to screen for mCRC  Read More »

May 6, 2013
Gains full control of cGMP manufacturing facility  Read More »

May 6, 2013
Will commit resources to global Oraxol, Oratecan  Read More »

May 3, 2013
Will use Ambrx's protein med-chem tech  Read More »

May 3, 2013
Deal worth as much as $50 million, plus royalties  Read More »

May 3, 2013
Expands market capabilities to include pharmaceutical use for Niacin  Read More »

May 3, 2013
Offers lab, office, and GMP production space for local pharma  Read More »

May 3, 2013
Revenues up 11% in the quarter with antiviral combos  Read More »

May 3, 2013
Specialty segment sales up 24% in the quarter  Read More »

May 2, 2013
Will combine methods for diabetes data collection  Read More »

May 2, 2013
Quart, Rosen, and Davis join management team  Read More »

May 2, 2013
To support diagnostic product development  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On